Long-Term Inflation Expectations Decline—A Boost for Health Sector Planning

Recent data from the University of Michigan’s July survey reveal that long-term inflation expectations have eased to 3.6%, offering a more stable outlook for healthcare cost planning. Recorded between June 24 and July 14, the consumer sentiment index rose to 61.8, up from 60.7 in June. This shift includes a dip in the 12-month outlook to 4.4% and, critically, the five- to ten-year inflation forecast falling to 3.6%—the lowest since February 2025—signaling a modest but meaningful retreat in inflation concerns.

For healthcare providers, insurers, and policymakers, this trend offers a welcome reprieve. Persistent cost uncertainty has plagued the sector, with key components such as medical labor, hospital services, pharmaceuticals, and high-cost treatments—including GLP-1 weight-loss medications—driving rapid cost increases. In 2025 alone, group and individual medical cost trends are forecasted to rise by 8% and 7.5%, respectively—the sharpest escalation in more than a decade.

A gradual decline in inflation expectations helps temper the projected inflation trajectory embedded in contracts and premiums. When insurers project long-term inflation, they build in cost buffers that are transmitted directly to consumer premiums. If forecasted inflation softens, these buffers can shrink, leading to more affordable coverage. In contrast, higher expectations would necessitate steeper premium increases to compensate. With the expectation falling to 3.6%, insurers can recalibrate their forecasts, potentially curbing the pace of rate hikes for 2026.

This shift could positively impact healthcare providers as well. Anticipated price stability in medical supplies, equipment, and labor can assist hospitals and clinics in negotiating vendor contracts with greater confidence. In sectors characterized by long-term investments—such as the acquisition of advanced medical technology or facility upgrades—lower inflation expectations can reduce uncertainty around return-on-investment calculations.

Nevertheless, short-term inflation remains elevated. The year-ahead expectation of 4.4%, albeit lower than June’s 5.0%, hints at persistent near-term cost pressures. This is supported by ongoing wage increases in healthcare, rising drug costs, and heightened demand for services—particularly in mental health and innovative treatment areas like GLP‑1 therapies. Insurers like Elevance Health and UnitedHealth have already revised medical cost growth projections higher, citing inflationary pressures in Medicaid and commercial lines.

These pressures are reverberating across the employer-sponsored insurance market. Mercer’s survey indicates that 51% of large U.S. employers intend to reduce health benefits in 2026—up from 45% in 2025—as a response to expensive medications and service costs. Similarly, KFF reports that insurers are proposing ACA premium increases averaging 15%—the steepest since 2018—driven by escalating expenses, waning subsidies, and sicker risk pools.

Understanding the decoupling of short- and long-term expectations is essential. Economists caution that while near-term inflation remains sticky, a dampening in longer-term outlooks suggests that consumers still believe the Federal Reserve can contain inflation over time. Goldman Sachs analysis notes that post-1995 long-term expectations typically remain bounded even amid short-term volatility.

Among healthcare stakeholders, the immediate focus is still on managing cost inflation in the coming months. Providers and payers alike can pursue strategies such as value-based care, enhanced price transparency, and tighter benefit controls to assuage short-term pressures. PwC highlights that leveraging biosimilars, digital interventions, and coordinated care are among the most effective levers for managing costs amid inflation.

Meanwhile, the drop in long-term inflation expectations opens a window for more measured planning. Contract terms for multi-year IT systems, hospital expansions, or capitation agreements can incorporate more realistic projections, reducing the margin of error. This period may also be opportune for reinsurers, rating agencies, and hospital boards to reassess risk frameworks under a more benign inflation outlook.

Overall, falling long-term inflation expectations act as a stabilizing force in a sector under intense cost pressure. By easing upward adjustments in premiums and reimbursement models, this trend provides short-term relief without sacrificing preparedness for future uncertainty. However, with near-term expectations remaining high, healthcare entities must balance immediate cost controls with long-horizon financial health.

As policymakers and industry leaders prepare for the 2026 planning cycle, the evolving inflation picture will be a central input. Will long-term expectations hold steady—or will renewed cost pressures push them higher again? Answers to that question may define the trajectory of healthcare financing in the years ahead.